Conor Killmurray

Dr. Richard J. Gralla discusses some of the studies in supportive care that have been put on hold due to the ongoing COVID-19 pandemic.

From the recent Beirut explosion compromising pediatric oncology hospitals, to researchers looking at how intestinal bacteria can supercharge targeted immunotherapies, here’s what’s happening in the cancer landscape this week.

Dr. Ricahrd J Gralla discusses the history of the early medical oncology space and how things have changed when it comes to treating side effects related to chemotherapy.

“Unlike other CAR T-cell therapies, clinical success was not associated with significant complications from therapy,” said Dr. Jonathan Serody. “This means this treatment should be available to patients in a clinic setting and would not require patients to be hospitalized, which is critical in our current environment.”

From the recent discovery of osteosarcoma in a dinosaur bone to NFL player Nate Solder opting out of the upcoming season for health concerns, here’s what’s making headlines in the cancer space this week.

While the combination of Opdivo and Yervoy is one of several treatment options for patients with metastatic renal cell carcinoma, many patients will likely progress after initial treatment. However, new research shows that when used after immune checkpoint inhibition, the combination shows promise.

Dr. Othman Al-Sawaf discusses the encouraging long-term data that makes the Venclexta-Gazyva combination a viable treatment option for patients with CLL.

From a new survey showing that more than one-third of Americans missed cancer screenings due to COVID-19 fears to a couple overcoming both COVID-19 and breast cancer, here’s what’s making the headlines in the cancer space this week.

From the death of civil rights icon John Lewis to a woman pretending to have cancer as part of a larger donation scam, here’s what’s making the headlines in the cancer space this week.

From U.S. Supreme Court Justice Ruth Bader Ginsburg being released from the hospital after an infection related to treatment for pancreatic tumor to Alex Trebek giving an update on the treatment of his stage 4 pancreatic cancer just days ahead of his 80th birthday, here’s what’s making the headlines in the cancer space this week.

Dr. Pat Basu, president and CEO of Cancer Treatment Centers of America discusses the fear surrounding cancer screenings during the COVID-19 pandemic and finding the right balance between what is an essential visit and what can be done using telemedicine.

From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.

From a care team giving a patient with metastatic breast cancer a taste of Paris after a planned trip had to be canceled to a local group of veterans honoring one of their own after a lung cancer diagnosis, here’s what’s making the headlines in the cancer space this week.

From the National Cancer Institute launching a nationwide study of patients with cancer who either have COVID-19 or are being tested for it to understand the disease to “St. Elmo’s Fire” and “Batman and Robin” director Joel Schumacher passing away from cancer, here’s what’s making the headlines in the cancer space this week.

The Food and Drug Administration granted accelerated approval to Xpovio for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who have undergone two prior therapies.

From a study showing a popular cancer side effect management steroid decreasing the risk of death for patients in the hospital with COVID-19 to a new liquid biopsy test detecting lingering cancer in DNA, here’s what’s making the headlines in the cancer space this week.

From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an experimental treatment, here’s what’s making the headlines in the cancer space this week.

The allogeneic “off-the-shelf” CAR-T cell therapy ALLO-501, paired with the monoclonal antibody ALLO-647, demonstrated clinical responses and a manageable safety profile in patients with pretreated large B-cell and follicular lymphomas.

From the Food and Drug Administration asking pharmaceutical companies to voluntarily recall metformin, a type 2 diabetes medication, as it contains high levels of the cancer-causing contaminant NDMA to an NHL team’s fanbase showing support to a player as he finishes treatment for Ewing sarcoma, here’s what is making the headlines in the cancer space this week.

Dr. Brad S. Kahl discusses the unique challenges that occur when treating patients with indolent non-Hodgkin lymphoma.

While follow-up data on the BEACON CRC study demonstrated superior overall survival for certain patients with metastatic colorectal cancer receiving Braftovi, Mektovi and Erbitux, an exploratory analysis is needed to understand if this treatment can impact a wider subset of patients.

Utilizing data from the INFORM registry, researchers were able to identify key biologic targets in pediatric patients with cancer utilizing an algorithm that matched them to targeted treatments with promising results.

The Food and Drug Administration approved the combination of Opdivo and Yervoy with 2 cycles of chemotherapy as a first-line treatment for certain patients with metastatic non-small cell lung cancer.

From Johnson & Johnson discontinuing their talc-based baby powder in the U.S. and Canada after numerous lawsuits that cited the talc, a mineral similar to asbestos, caused cancer, to the ramifications of delayed cancer surgeries being felt by patients, here’s everything happening in the cancer space this week.

The Food and Drug Administration’s approval of the PARP inhibitor Lynparza for patients with metastatic prostate cancer gives a smaller subgroup of patients another treatment option if hormonal therapies do not work.

The COVID-19 pandemic is halting and slowing down clinical trials, and the Food and Drug Administration is offering guidelines to adjust to these new challenges.

The Food and Drug Administration has approved the combination of Opdivo-Yervoy immunotherapy for the first-line treatment of patients with metastatic non-small cell lung cancer that do not have certain genomic tumor aberrations.

From influential musician Little Richard passing away due to bone cancer to a dramatic drop in new cancer diagnoses as screenings have been postponed as a result of COVID-19, here are all the major updates happening in the cancer space this week.

“It’s never too late to quit smoking,” is the primary message of a new study that shows those who quit smoking have a survival benefit prior to a lung cancer diagnosis.   

Further follow up of the CheckMate-214 trial continues to show the superior long-term outcomes of Opdivo and Yervoy in treatment of patients with advanced renal cell carcinoma.